MESA LABORATORIES INC /CO/
Financial highlights
| Metric | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 | FY 03/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $241.0M | $216.2M | $219.1M | $184.3M | $133.9M |
| Cost of revenue | $90.1M | $82.9M | $85.4M | $75.2M | $46.9M |
| Gross profit | $150.9M | $133.2M | $133.7M | $109.1M | $87.0M |
| Research and development | $19.5M | $19.3M | $20.5M | $15.8M | $10.4M |
| Operating expenses | $134.5M | $405.3M | $130.4M | $104.4M | $74.7M |
| Operating income | $16.3M | -$272.1M | $3.3M | $4.7M | $12.4M |
| Interest expense | $11.9M | $5.7M | $4.8M | $3.9M | $8.0M |
| Pretax income | $6.0M | -$275.6M | -$389,000 | $3.6M | $2.3M |
| Income tax expense | $7.9M | -$21.4M | -$1.3M | $1.7M | -$971,000 |
| Net income | -$2.0M | -$254.2M | $930,000 | $1.9M | $3.3M |
| Balance Sheet | |||||
| Cash and equivalents | $27.3M | $28.2M | $32.9M | $49.3M | $263.9M |
| Current assets | $102.7M | $109.4M | $119.0M | $124.3M | $303.7M |
| Total assets | $433.3M | $446.8M | $661.8M | $707.4M | $601.5M |
| Current liabilities | $164.0M | $44.3M | $43.4M | $48.1M | $32.6M |
| Total liabilities | $273.5M | $301.4M | $268.4M | $313.6M | $195.2M |
| Stockholders' equity | $159.8M | $145.4M | $393.5M | $393.8M | $406.2M |
| Cash Flow Statement | |||||
| Cash from operations | $46.8M | $44.1M | $28.0M | $39.2M | $37.1M |
| Depreciation and amortization | $5.4M | $4.2M | $33.8M | $25.1M | $17.7M |
| Stock-based compensation | $13.1M | $11.9M | $12.5M | $11.4M | $9.3M |
| Capital expenditure | $4.2M | $2.6M | $4.5M | $4.4M | $2.0M |
| Free cash flow | $42.6M | $41.6M | $23.4M | $34.8M | $35.1M |
| Dividends paid | $3.5M | $3.4M | $3.4M | $3.3M | $3.2M |
| Share repurchases | — | $0 | $0 | $0 | $0 |
| Impairments | $0 | $156.9M | $0 | $0 | $0 |
Shares outstanding 5.5M · Free float 93.8%
Annual filing data through FY ended March 31, 2025; float as of July 8, 2026.